1 – 96 of 96
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The natural history of progressive myoclonus Ataxia
(
- Contribution to journal › Article
-
Mark
Preventive cognitive protection based on AAV9 overexpression of IGF1 in hippocampal astrocytes
(
- Contribution to journal › Article
- 2023
-
Mark
Neurofilament light predicts worse nonmotor symptoms and depression in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Optogenetics for controlling seizure circuits for translational approaches
(
- Contribution to journal › Article
- 2021
-
Mark
Viral-based rodent and nonhuman primate models of multiple system atrophy : Fidelity to the human disease
(
- Contribution to journal › Article
-
Mark
Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of parkinsonism
(
- Contribution to journal › Article
-
Mark
DNAJB6 suppresses alpha-synuclein induced pathology in an animal model of Parkinson's disease
(
- Contribution to journal › Article
- 2020
-
Mark
Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration : A translatable marker of synaptic degeneration
(
- Contribution to journal › Article
- 2019
-
Mark
Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Heritability and genetic variance of dementia with Lewy bodies
(
- Contribution to journal › Article
-
Mark
Leptin deficiency reverses high metabolic state and weight loss without affecting central pathology in the R6/2 mouse model of Huntington's disease
(
- Contribution to journal › Article
- 2018
-
Mark
Chemogenetic modulation of cholinergic interneurons reveals their regulating role on the direct and indirect output pathways from the striatum
(
- Contribution to journal › Article
-
Mark
Prion-like seeding and nucleation of intracellular amyloid-β
(
- Contribution to journal › Article
-
Mark
Changes in resting-state functional connectivity after stroke in a mouse brain lacking extracellular matrix components
(
- Contribution to journal › Article
-
Mark
Parkinson's disease-like burst firing activity in subthalamic nucleus induced by AAV-α-synuclein is normalized by LRRK2 modulation
(
- Contribution to journal › Article
- 2017
-
Mark
Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration
(
- Contribution to journal › Article
-
Mark
Functional validation of ABHD12 mutations in the neurodegenerative disease PHARC
(
- Contribution to journal › Article
-
Mark
Amplifying mitochondrial function rescues adult neurogenesis in a mouse model of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Gene therapy for Parkinson's disease : Disease modification by GDNF family of ligands
(
- Contribution to journal › Scientific review
-
Mark
Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington's disease
(
- Contribution to journal › Article
- 2016
-
Mark
Platelet-derived growth factor-BB has neurorestorative effects and modulates the pericyte response in a partial 6-hydroxydopamine lesion mouse model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Validation of an improved scale for rating L-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists
(
- Contribution to journal › Article
-
Mark
Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model
(
- Contribution to journal › Article
-
Mark
Dramatic differences in susceptibility to L-DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion
(
- Contribution to journal › Article
-
Mark
Translational approach for gene therapy in epilepsy: Model system and unilateral overexpression of neuropeptide Y and Y2 receptors.
(
- Contribution to journal › Article
- 2015
-
Mark
Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models.
(
- Contribution to journal › Article
-
Mark
A cell culture model for monitoring α-synuclein cell-to-cell transfer.
(
- Contribution to journal › Article
-
Mark
Cystamine/cysteamine rescues the dopaminergic system and shows neurorestorative properties in an animal model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Inflammation without neuronal death triggers striatal neurogenesis comparable to stroke.
(
- Contribution to journal › Article
-
Mark
Reconstruction of brain circuitry by neural transplants generated from pluripotent stem cells.
(
- Contribution to journal › Scientific review
-
Mark
Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: A speculative synthesis.
(
- Contribution to journal › Scientific review
-
Mark
Rodent models of impulsive compulsive behaviors in Parkinson's disease: how far have we reached?
(
- Contribution to journal › Scientific review
-
Mark
Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function.
(
- Contribution to journal › Article
-
Mark
Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.
(
- Contribution to journal › Article
-
Mark
Role of fractalkine-CX3CR1 pathway in seizure-induced microglial activation, neurodegeneration, and neuroblast production in the adult rat brain.
(
- Contribution to journal › Article
- 2014
-
Mark
Enriched housing down-regulates the Toll-like receptor 2 response in the mouse brain after experimental stroke.
(
- Contribution to journal › Article
-
Mark
The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation.
(
- Contribution to journal › Article
-
Mark
Optogenetic inhibition of chemically induced hypersynchronized bursting in mice.
(
- Contribution to journal › Article
-
Mark
GABAA receptor dephosphorylation followed by internalization is coupled to neuronal death in in vitro ischemia.
2014) In Neurobiology of Disease(
- Contribution to journal › Article
- 2013
-
Mark
Efficient expansion and dopaminergic differentiation of human fetal ventral midbrain neural stem cells by midbrain morphogens
(
- Contribution to journal › Article
-
Mark
Grafted human neural stem cells enhance several steps of endogenous neurogenesis and improve behavioral recovery after middle cerebral artery occlusion in rats.
(
- Contribution to journal › Article
-
Mark
Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP.
(
- Contribution to journal › Article
-
Mark
Comparison of rating scales used to evaluate L-DOPA-induced dyskinesia in the 6-OHDA lesioned rat
(
- Contribution to journal › Article
- 2012
-
Mark
Dysregulated dopamine storage increases the vulnerability to alpha-synuclein in nigral neurons
(
- Contribution to journal › Article
-
Mark
Special Issue: Viral delivery of genes: new frontiers Introduction
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.
(
- Contribution to journal › Article
-
Mark
Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures
(
- Contribution to journal › Article
-
Mark
In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to l-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels
(
- Contribution to journal › Article
-
Mark
Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brain
(
- Contribution to journal › Scientific review
-
Mark
Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease.
(
- Contribution to journal › Article
- 2011
-
Mark
Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Enriched environment downregulates macrophage migration inhibitory factor and increases parvalbumin in the brain following experimental stroke
(
- Contribution to journal › Article
-
Mark
Cleavage of the vesicular glutamate transporters under excitotoxic conditions
(
- Contribution to journal › Article
-
Mark
Apoptosis-inducing factor mediates dopaminergic cell death in response to lps-induced inflammatory stimulus Evidence in Parkinson's disease patients.
(
- Contribution to journal › Article
-
Mark
Gastrointestinal dysfunction contributes to weight loss in Huntington's disease mice.
(
- Contribution to journal › Article
- 2010
-
Mark
A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys.
(
- Contribution to journal › Article
-
Mark
Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis.
(
- Contribution to journal › Article
- 2009
-
Mark
Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Increased levels of cocaine and amphetamine regulated transcript in two animal models of depression and anxiety.
(
- Contribution to journal › Article
- 2008
-
Mark
Increased metabolism in the R6/2 mouse model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
In vivo gene delivery to proliferating cells in the striatum generated in response to a 6-hydroxydopamine lesion of the nigro-striatal dopamine pathway
(
- Contribution to journal › Article
-
Mark
Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation
(
- Contribution to journal › Article
- 2007
-
Mark
Soluble adhesion molecules and angiotensin-converting enzyme in dementia.
(
- Contribution to journal › Article
-
Mark
Testicular degeneration in Huntington disease
(
- Contribution to journal › Article
-
Mark
Re-evaluation of mitochondrial permeability transition as a primary neuroprotective target of minocycline.
(
- Contribution to journal › Article
-
Mark
Nerve growth factor promotes survival of new neurons in the adult hippocampus.
(
- Contribution to journal › Article
- 2006
-
Mark
The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat.
(
- Contribution to journal › Article
-
Mark
Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Prostaglandin E(2) and BDNF levels in rat hippocampus are negatively correlated with status epilepticus severity: No impact on survival of seizure-generated neurons.
(
- Contribution to journal › Article
-
Mark
Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.
(
- Contribution to journal › Article
-
Mark
Genetically determined susceptibility to neurodegeneration is associated with expression of inflammatory genes
(
- Contribution to journal › Article
- 2005
-
Mark
Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice.
(
- Contribution to journal › Article
-
Mark
Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors.
(
- Contribution to journal › Article
-
Mark
Cystatin C modulates neurodegeneration and neurogenesis following status epilepticus in mouse
(
- Contribution to journal › Article
-
Mark
Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction.
(
- Contribution to journal › Article
-
Mark
Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice
(
- Contribution to journal › Article
-
Mark
Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses
(
- Contribution to journal › Article
- 2004
-
Mark
Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia
(
- Contribution to journal › Article
-
Mark
Status epilepticus severity influences the long-term outcome of neurogenesis in the adult dentate gyrus.
(
- Contribution to journal › Article
-
Mark
Effects of pulsatile L-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy)
(
- Contribution to journal › Article
-
Mark
A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function.
(
- Contribution to journal › Article
- 2003
-
Mark
Death mechanisms in status epilepticus-generated neurons and effects of additional seizures on their survival.
(
- Contribution to journal › Article
-
Mark
Elevated GDNF levels following viral vector-mediated gene transfer can increase neuronal death after stroke in rats.
(
- Contribution to journal › Article
-
Mark
Targeted expression of BCL-2 attenuates MPP+ but not 6-OHDA induced cell death in dopaminergic neurons
(
- Contribution to journal › Article
-
Mark
Kindling alters entorhinal cortex-hippocampal interaction by increased efficacy of presynaptic GABA(B) autoreceptors in layer III of the entorhinal cortex
(
- Contribution to journal › Article
- 2002
-
Mark
L-DOPA-Induced Dyskinesia in the Intrastriatal 6-Hydroxydopamine Model of Parkinson's Disease: Relation to Motor and Cellular Parameters of Nigrostriatal Function.
(
- Contribution to journal › Article
-
Mark
Neuropathological and behavioral consequences of adeno-associated viral vector-mediated continuous intrastriatal neurotrophin delivery in a focal ischemia model in rats.
(
- Contribution to journal › Article
-
Mark
Interactions of A beta with endogenous anti-inflammatory agents: a basis for chronic neuroinflammation in Alzheimer's disease.
(
- Contribution to journal › Scientific review
-
Mark
Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice.
(
- Contribution to journal › Article
- 2001
-
Mark
Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of L-DOPA-induced dyskinesia
(
- Contribution to journal › Article
-
Mark
Alterations of Akt1 (PKBalpha) and p70(S6K) in transient focal ischemia
(
- Contribution to journal › Article
- 1997
-
Mark
Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease
(
- Contribution to journal › Scientific review